Digital Events | Kisaco Research
Filter by:
Animal Microbiome Congress 2021
24-25 Mar 2021
Virtual Event
Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries.Current research strongly indicates that animal microbiome modulation could greatly improve pet health and increase the meat industry’s productivity, while ensuring that it meets its sustainability targets. Consequently, significant profits can be created by overcoming the obstacles in reproducing animal microbiome research in industry and quicker returns can be obtained by translating the more advanced human microbiome technology to modulate the animal microbiome. However, these commercial rewards can only be realised by steering through tough legal and regulatory obstacles smartly.Our goal is to support smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market. 
2021 Microbiome Connect Nutrition
1-2 Jun 2021
Research into the gut microbiome has positioned the industry at the core of personalized nutrition and diet. With the global market of probiotics projected to be worth $64Bn by 2024 and a boom in consumer consciousness around wellness following the pandemic, a new wave of product development is occurring.Microbiome Connect: Nutrition is the second global event dedicated to transforming microbiome R&D into consumer products that promote wellbeing. Tune in to meet the nutrition ecosystem across; big nutrition, consumer Health, CPG companies, independent nutrition brands, ingredients producers and formulators. Key challenges and solutions being discussed include;Customer retention - Retain customers through gut microbiome personalized diagnosticsand regimes.Claims development - Develop a better understanding of the regulatory status of products and the claims that can be made and establish methodology for developing trials to establish new claims for their productsPartnerships - Network across the ecosystem leading to new product development partnerships, investment and supply-chain.Product development - Protecting IP and enaching product development and pipeline.Trend identification - Develop better consumer insights to determine the scientific language consumers and understand and what they will buy through spotting future trends. Utilize these learnings in the branding of marketing of your products.Join Microbiome Connect: Nutrition to meet with science and business leaders from the microbiome field to transform microbiome research and innovation into successful and effective consumer products.
Women's Health Innovation Series: Women 40+ Innovation Summit
22-23 Jun 2021
Whilst there has been an improved focus on Women’s Health and Femtech Innovations, the industry has yet to extend its innovative arm to the unmet needs of women at the mid-stage of life. Often described as the ‘invisible’ age bracket, the health needs of women at this pivotal life-stage have been severely neglected, reflecting a poor understanding of both the magnitude of unmet need, and the commercial potential of creating solutions.The Women 40+ Innovation Summit, is the leading network of entrepreneurs, practitioners and industry leaders who are committed to investing in better health solutions and outcomes for women at an often challenging and transitional phase of life. As the recognised hub for innovation, collaboration and partnership, we will be exploring a broad cross-section of health concerns including menopause, perimenopause, healthy ageing (or aging well!), osteoporosis, incontinence, mental health and female -prevalent cancers. We will be joined by: pharmaceutical companies, biotechs, start-ups, telehealth companies, HCPs, investors, top CP’s and genetic testing innovators to drive solutions, awareness and spark discussion that will facilitate the partnerships and investments needed to advance the industry.
Filter by:
Microbiome Connect - Skin - EU 2020
10-11 Nov 2020
2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty and personal care have recognised the potential commercial value of skin microbiome-based consumer product claims and formulations. Moving forward into 2021, the market will continue to see more and more products launched with microbiome claims backed through next-generation sequencing techniques. Including ingestible beauty products that influence the gut-skin axis, to truly personalized skincare solutions and mass market formulations – there’s a huge commercial opportunity to commercialise skin microbiome research into consumer care products. So, what’s different at Microbiome Connect: Skin EU Virtual? Six new topics to explore:The skin-gut axis and the development of ingestible beauty products.Personalisation of skin-microbiome products and formulation considerations.Defining skin-microbiome industry terminology and developing scientifically backed claims that resonate with consumers.Next generation sequencing techniques and their application in claims development.New data demonstrating the role of the microbiome in common skin conditions including acne, eczema and dandruff.The vaginal and oral microbiomes and the mass market product development opportunities to treat gingivitis/periodontitis and sexually transmitted infections.
Microbiome Connect : Human - USA 2020
3-5 Jun 2020
The gut microbiome is becoming an increasingly important druggable target for pharma companies through a range of modalities from FMT to small molecule and even phage. 2020 looks set to be a pivotal year for the microbiome industry with a handful of companies (including Seres, Rebiotix and Finch Therapeutics) set to release ground-breaking phase 3 clinical data. We’re a step away from market approval, but there’s still so much to learn…Major advances in shotgun metagenomic sequencing and computational biology allow us to see what’s going on at a strain-specific and metabolomic level of detail. Elucidating the key metabolites and mechanisms of action in both extra-intestinal and intestinal indications is a key objective in 2020/2021 and is a cornerstone of the discussion at Microbiome Connect: Human. Join key opinion leaders to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications. This is your opportunity to translate gut-microbiome research into therapeutics that have the power to treat oncological, neurological, gastro-intestinal & metabolic diseases.Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge. 
Microbiome Connect - Skin - USA 2020
3-5 Jun 2020
2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there…This year is all about the major advancements of sequencing and analysis in this space, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products, skin conditions, personalization, skin-gut supplements, and anti-aging. Building on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical, Beauty and Personal Care, Independent Skincare Brands, Bio-techs, Researchers and Academics, Kisaco Research presents Microbiome Connect: Skin USA, an all-encompassing event, which runs alongside Microbiome Connect: Human USA as a virtual event, June 3 - 5.What’s different?This year, you can expect 5 unique topics, more attendees and more networking opportunities to explore:Ground-breaking research into how best treat these skin diseases and develop treatments targeting acne vulgaris, atopic dermatitis, psoriasis Vulgaris and rosacea.The translation and commercialization of product claims, the latest trends and protecting your intellectual property.The convergence between the skin-gut axis and the supplement market.Personalized formulation and product developmentTools to increase product claims using sequencing and bioinformatics.Join key opinion leaders and expert speakers across three days to translate the latest skin microbiome data and market analysis into truly commercial and competitive beauty and personal care products.Skin microbiome based-products have been disrupting the beauty industry for the past two years, the question is, how can you differentiate your products?